The tape has that hollow, echo-chamber feel you only get before a major regime test—where every tick feels like a market trying to inhale without knowing whether the next exhale will be relief or ...

Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...

Baidu unveils a powerful open-source AI model that rivals Google and OpenAI in visual reasoning, multimodal analysis, and enterprise efficiency using just a fraction of computing power.

Novo Nordisk (NVO), the Danish pharmaceutical giant behind blockbuster obesity and diabetes treatments Ozempic and Wegovy, finds itself at a technical breaking point that could define its trajectory ...

Fermi Inc. is a early-stage REIT aiming to deliver over 11 GW of low-carbon power for AI data centers by 2038. Read more on ...